Cargando…
Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546399/ https://www.ncbi.nlm.nih.gov/pubmed/35655425 http://dx.doi.org/10.1111/pcn.13432 |
| _version_ | 1784805033896837120 |
|---|---|
| author | Takeshima, Masahiro Enomoto, Minori Ogasawara, Masaya Kudo, Mizuki Itoh, Yu Yoshizawa, Kazuhisa Fujiwara, Dai Takaesu, Yoshikazu Mishima, Kazuo |
| author_facet | Takeshima, Masahiro Enomoto, Minori Ogasawara, Masaya Kudo, Mizuki Itoh, Yu Yoshizawa, Kazuhisa Fujiwara, Dai Takaesu, Yoshikazu Mishima, Kazuo |
| author_sort | Takeshima, Masahiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9546399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95463992022-10-14 Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database Takeshima, Masahiro Enomoto, Minori Ogasawara, Masaya Kudo, Mizuki Itoh, Yu Yoshizawa, Kazuhisa Fujiwara, Dai Takaesu, Yoshikazu Mishima, Kazuo Psychiatry Clin Neurosci Letters to the Editor John Wiley & Sons Australia, Ltd 2022-07-02 2022-09 /pmc/articles/PMC9546399/ /pubmed/35655425 http://dx.doi.org/10.1111/pcn.13432 Text en © 2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Takeshima, Masahiro Enomoto, Minori Ogasawara, Masaya Kudo, Mizuki Itoh, Yu Yoshizawa, Kazuhisa Fujiwara, Dai Takaesu, Yoshikazu Mishima, Kazuo Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database |
| title | Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database |
| title_full | Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database |
| title_fullStr | Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database |
| title_full_unstemmed | Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database |
| title_short | Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database |
| title_sort | changes in psychotropic polypharmacy and high‐potency prescription following policy change: findings from a large scale japanese claims database |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546399/ https://www.ncbi.nlm.nih.gov/pubmed/35655425 http://dx.doi.org/10.1111/pcn.13432 |
| work_keys_str_mv | AT takeshimamasahiro changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT enomotominori changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT ogasawaramasaya changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT kudomizuki changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT itohyu changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT yoshizawakazuhisa changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT fujiwaradai changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT takaesuyoshikazu changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase AT mishimakazuo changesinpsychotropicpolypharmacyandhighpotencyprescriptionfollowingpolicychangefindingsfromalargescalejapaneseclaimsdatabase |